|
| 1 | +layout: learning-pathway |
| 2 | +tags: [intermediate, immunopeptidomics, cancer, proteogenomics, label-free] |
| 3 | +type: use |
| 4 | + |
| 5 | +title: Prediction of potential neoantigens |
| 6 | +description: | |
| 7 | + This learning path introduces a comprehensive immunopeptidogenomics workflow for neoantigen discovery using label-free mass spectrometry data. The modules guide you through fusion and variant database generation, peptide identification with FragPipe, peptide validation using PepQuery2, and immunogenicity assessment through HLA binding predictions and IEDB screening. |
| 8 | + |
| 9 | +cover-image: shared/images/proteomics.png |
| 10 | +cover-image-alt: image of a 3D protein folding structure |
| 11 | + |
| 12 | +editorial_board: |
| 13 | +- subinamehta |
| 14 | + |
| 15 | +pathway: |
| 16 | + - section: "Neoantigen 1: Fusion-Database Generation" |
| 17 | + description: | |
| 18 | + Learn how to generate a personalized fusion peptide database using RNA-seq data. This step sets the foundation for identifying tumor-specific fusion peptides in downstream analyses. |
| 19 | + tutorials: |
| 20 | + - name: neoantigen-1-fusion-db-generation |
| 21 | + topic: proteomics |
| 22 | + |
| 23 | + - section: "Neoantigen 2: Non-Reference Database Generation" |
| 24 | + description: | |
| 25 | + Construct a non-reference proteogenomic database incorporating somatic mutations, indels, and other genomic alterations from VCF data. |
| 26 | + tutorials: |
| 27 | + - name: neoantigen-2-non-reference-database-generation |
| 28 | + topic: proteomics |
| 29 | + |
| 30 | + - section: "Neoantigen 3: Database Merge and FragPipe Discovery" |
| 31 | + description: | |
| 32 | + Merge the fusion and non-reference databases, then use FragPipe for mass spectrometry-based discovery of putative neopeptides. |
| 33 | + tutorials: |
| 34 | + - name: neoantigen-3-fragpipe-discovery |
| 35 | + topic: proteomics |
| 36 | + |
| 37 | + - section: "Neoantigen 4: PepQuery2 Verification" |
| 38 | + description: | |
| 39 | + Perform targeted verification of neoantigen candidates using PepQuery2 for peptide-spectrum match validation. |
| 40 | + tutorials: |
| 41 | + - name: neoantigen-4-peptide-verification |
| 42 | + topic: proteomics |
| 43 | + |
| 44 | + - section: "Neoantigen 5: Variant Annotation" |
| 45 | + description: | |
| 46 | + Annotate validated neopeptides with their corresponding genomic variants and protein context. |
| 47 | + tutorials: |
| 48 | + - name: neoantigen-5-variant-annotation |
| 49 | + topic: proteomics |
| 50 | + |
| 51 | + - section: "Neoantigen 6: Predicting HLA Binding" |
| 52 | + description: | |
| 53 | + Predict MHC binding affinity of validated neopeptides using tools such as NetMHCpan or similar. |
| 54 | + tutorials: |
| 55 | + - name: neoantigen-6-predicting-hla-binding |
| 56 | + topic: proteomics |
| 57 | + |
| 58 | + - section: "Neoantigen 7: IEDB Binding of PepQuery Validated Neopeptides" |
| 59 | + description: | |
| 60 | + Assess immunogenic potential of neopeptides by checking their binding predictions against immune epitope databases such as IEDB. |
| 61 | + tutorials: |
| 62 | + - name: neoantigen-7-hla-binding-novel-peptides |
| 63 | + topic: proteomics |
| 64 | + |
| 65 | +--- |
| 66 | + |
| 67 | +New to immunopeptidogenomics or neoantigen prediction? Follow this learning path to discover how label-free mass spectrometry and proteogenomic integration can accelerate identification of clinically relevant neoantigens and help in personalized immunotherapy. |
0 commit comments